Related Experiment Videos
Purinoceptors in the nervous system
1Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Pharmacology & Toxicology
|April 1, 1995
Summary
Adenosine and ATP are crucial purines in the nervous system, acting on distinct receptors. Adenosine (A1, A2A) influences neurotransmitter release and dopamine pathways, while ATP targets P2 receptors, offering drug development potential.
Area of Science:
- Neuroscience
- Pharmacology
- Molecular Biology
Background:
- Adenosine and Adenosine Triphosphate (ATP) are vital purines in the central nervous system.
- They exert distinct physiological effects by interacting with specific receptor families.
Purpose of the Study:
- To review the roles of adenosine and ATP in the nervous system.
- To discuss the classification and function of purinergic receptors, including P1 (adenosine) and P2 (ATP) receptors.
Main Methods:
- Pharmacological characterization and cloning of adenosine receptors (A1, A2A, A2B, A3).
- Review of existing literature on purinergic signaling pathways.
- Discussion of receptor subclassification for P2 purinoceptors.
Main Results:
- Adenosine receptors (P1 purinoceptors) are G protein-coupled receptors.
- Adenosine acting on A1 receptors regulates neurotransmitter release.
- Adenosine acting on A2A receptors modulates dopaminergic transmission.
- ATP receptors (P2 purinoceptors) include G protein-coupled receptors and ion channels.
Conclusions:
- Purinergic signaling via adenosine and ATP is critical for nervous system function.
- Further understanding of purinergic receptors facilitates drug development.
- Targeting purines and their receptors holds therapeutic potential.